Dr. Nikolas Hans Blevins, MD

Dr. Blevins practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Blevins' NPI, 1093863169, was assigned on January 8, 2007. Dr. Blevins graduated from Harvard Medical School in 1988. Dr. Blevins holds California license G68567.

Dr. Blevins' primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Blevins' primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Blevins to 1 more hospital, named with a free account. Dr. Blevins' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blevins practices, 2 sites in all. Vendor and product names are available with a free account.

Otology and neurotology is Dr. Blevins' primary specialty in the NPI Registry, under taxonomy code 207YX0901X. Dr. Blevins is board certified in neurotology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Blevins' licenses on file in 3 states: California, Massachusetts and Rhode Island.

Dmand AI lists chronic ear infection, ear eustachian tube disorders, ear infection, hearing loss and impairment, swimmer's ear and vertigo among the conditions Dr. Blevins treats.

CMS data shows 412 Medicare services from Dr. Blevins across 5 procedure codes in 2024, for 280 Medicare patients. Medicare paid $42,437 for them.

CMS counts 280 Medicare patients who saw Dr. Blevins in 2024. The largest group is 65 to 74, with 112 patients. 74% of them have high cholesterol, and 66% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Blevins' median patient age at 61, with 55% women.

In 2024, Dr. Blevins wrote 72 Medicare Part D claims for 34 patients. 81% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $2,077 in total drug cost. In 2019, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Blevins for performance year 2024, reported as part of a group. Dr. Blevins accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Blevins as offering telehealth.

Dmand AI links 110 papers to Dr. Blevins, published from 2006 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Tomography, X-Ray Computed, Temporal Bone and Cochlear Implantation. Dr. Blevins has published most often in Otol Neurotol. Dr. Blevins' most frequent co-authors are Robert Keith Jackler, MD, Jennifer Christy Alyono, MD and Yona Vaisbuch, MD.

CMS Open Payments shows 19 general payments to Dr. Blevins from 5 drug and device companies from 2016 to 2025. Education make up the largest share, 89% of the total. MED-EL Corporation paid the most, $6,234.

Dmand AI lists 3 awards for Dr. Blevins, most recently Regional Top Doctor in 2014.

Dr. Blevins graduated from Harvard Medical School in 1988. Dr. Blevins is a member of NHS.

Dr. Blevins is in network with 10 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.